●
●
Weaknesses
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.63 times its estimated earnings per share for the ongoing year.
●
●
● The company is not the most generous with respect to shareholders' compensation.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.